January 2011 Editor's Picks: Products from AdvantaPure and NETZSCH Premier Technologies - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

January 2011 Editor's Picks: Products from AdvantaPure and NETZSCH Premier Technologies

Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

product AdvantaPure
Overmolded fittings reduce entrapment

AdvantaPure’s Overmolded Tri-Clamp Ends are suitable for applications such as transferring media, dispensing, and final filling. Because polypropylene fittings are thermally mated to the end of the tubing, the overmolded products provide a completely smooth inner diameter that reduces the opportunity for bacterial entrapment, compared with barb-type fittings. The overmolded fittings also eliminate leakage and minimize the risk of contamination because they do not rely on mechanical connections.

The Overmolded Tri-Clamp fittings are available for various sizes of polyvinyl chloride, thermoplastic elastomer, and thermoplastic rubber tubing. The fittings do not restrict flow or the inner diameter of the tubing. Clients can choose fitting models that are injection molded from US Pharmacopoeia Class VI thermoplastic polyester elastomers or polypropylene. The Tri-Clamp Ends are certified free of animal-derived ingredients and are designed to be cleaned and sterilized easily. In addition, AdvantaPure can provide molded silicone assemblies and various single-use process components.


productNETZSCH Premier Technologies
Nanoparticle mills provide efficiency and control

The DeltaVita line of ultrafine nanoparticle mills from NETZSCH Premier Technologies includes devices appropriate for the wet grinding of batch sizes from 0.05 to 2000 L. The mills’ high-energy input and high flow rates in a recirculation process enable them to complete 10 cycles in the time it takes other mills to complete one. Continuous high-flow throughput ensures that the entire batch passes the mill several times before the process is completed while the batch tank is continuously agitated. The milling process is continuously monitored, which helps control the end point of the process and yield the desired product quality.

The DeltaVita mills incorporate NETZSCH’s Zeta grinding system, which uses small grinding media to produce fine end products in the nanometer range. The machines are designed for easy cleaning, repeatability, and easy validation. The units are isolated for operator safety, and their wetted parts are manufactured according to good manufacturing practice standards.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
25%
To select processes for both new and legacy products
20%
Do not use QbD
23%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Equipment and Processing Report,
Click here